跳至主要内容
临床试验/EUCTR2019-004834-40-BE
EUCTR2019-004834-40-BE进行中(未招募)1 期

Do peri-operative high doses of intravenous glucocorticoids improve short-term functional outcome after direct anterior total hip arthroplasty? A randomized, single surgeon, placebo controlled, double blind study

niversity Hospitals Leuven0 个研究点目标入组 70 人开始时间: 2020年4月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • - All patients undergoing unilateral uncemented THA for primary OA of AVN of the hip under general anesthesia (GA)
  • - Aged 18 years and above (including women of child bearing age)
  • - Able to provide informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • - Younger than 18 years
  • - Known alcohol or drug abuse
  • - Known allergy for glucocorticoids
  • - Administration of any glucocorticoids in the last three months
  • - Usage of strong analgesia (such as lyrica, oxycodone) as regular medication
  • - Usage of medication with anticipated interactions with glucocorticoids
  • - Known gastric ulcer
  • - Insulin dependent diabetes mellitus
  • - Severe heart disease (NYHA > 2)
  • - Liver or renal failure
  • - Systemic rheumatoid diseases
  • - Insufficient understanding of the Dutch language
  • - Unable to provide informed consent
  • - Pre-operative use of walking aids
  • - Gross anatomical deformities
  • - Significant intra-operative complication such as peri-prosthetic fracture

研究者

发起方
niversity Hospitals Leuven

相似试验